Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines.
about
Outer membrane vesicles displaying engineered glycotopes elicit protective antibodiesEffect of B7-2 and CD40 signals from activated antigen-presenting cells on the ability of zwitterionic polysaccharides to induce T-Cell stimulation.Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial.Protective levels of polysaccharide-specific maternal antibodies may enhance the immune response elicited by pneumococcal conjugates in neonatal and infant mice.A novel ICOS-independent, but CD28- and SAP-dependent, pathway of T cell-dependent, polysaccharide-specific humoral immunity in response to intact Streptococcus pneumoniae versus pneumococcal conjugate vaccine.Combined conjugate vaccines: enhanced immunogenicity with the N19 polyepitope as a carrier protein.Isolation of carbohydrate-specific CD4(+) T cell clones from mice after stimulation by two model glycoconjugate vaccinesImmunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levelsOuter membrane protein complex of Meningococcus enhances the antipolysaccharide antibody response to pneumococcal polysaccharide-CRM₁₉₇ conjugate vaccine.The nature of an in vivo anti-capsular polysaccharide response is markedly influenced by the composition and/or architecture of the bacterial subcapsular domain.Intact reducing glycan promotes the specific immune response to lacto-N-neotetraose-BSA neoglycoconjugates.Structurally identical capsular polysaccharide expressed by intact group B streptococcus versus Streptococcus pneumoniae elicits distinct murine polysaccharide-specific IgG responses in vivoDifferential idiotype utilization for the in vivo type 14 capsular polysaccharide-specific Ig responses to intact Streptococcus pneumoniae versus a pneumococcal conjugate vaccineA mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design.Inflammatory monocytes are critical for induction of a polysaccharide-specific antibody response to an intact bacteriumRational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching.Conjugation of polysaccharide 6B from Streptococcus pneumoniae with pneumococcal surface protein A: PspA conformation and its effect on the immune responseNovel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.A novel tetrameric gp350 1-470 as a potential Epstein-Barr virus vaccine.Carbohydrates and T cells: a sweet twosome.Enhancement of serum and mucosal immune responses to a Haemophilus influenzae Type B vaccine by intranasal delivery.B cell mediated priming following pneumococcal colonization
P2860
Q28831290-A7DB3D5D-56A1-4DCA-8192-3C4F8506E9D1Q33769317-F985C7BB-54D9-4EC7-BBCD-7DF7E501B801Q33788106-86B292D2-FA8A-446F-9F97-A018DE3AA3C5Q33792707-C69F8F47-1E15-4282-97EC-6FA4229CFCC9Q33944575-2622D795-F446-4C0F-BE7A-B838C2F6DB85Q34034071-F68573AB-B84D-4AEE-A935-33FC6A29EA35Q34049012-AE8829B5-BDAC-4EED-97ED-0DBBD5BA2DE5Q34492738-D52241DA-4C4B-4EB5-B929-C4B627821254Q35066102-931A855C-A3D2-41C7-A258-3129F55E7EB0Q35659235-7D453CA1-9A90-4177-B540-8FC4BF26EDBBQ35897201-AB284658-AF69-4CD3-A505-D081CFCF2B67Q35980776-EBBF4076-66C4-4B81-AF8A-05AD7B17E434Q36084183-E614470F-E452-42C4-A3DE-6711B18521D2Q36351293-026B69E2-FFA9-4336-8053-4EC9CCBC336DQ36545997-C5A216F7-ADA2-4D9A-99AB-3F9CE0818416Q36557966-2A0A6D3E-DA0A-4279-9F9B-338E7EB21B4DQ36911270-5EDD3EFE-8864-4F3A-80D7-2140C3A4B81DQ36970896-5EBDC817-997F-4607-A130-0607197357A4Q36979271-02466E3F-B0F4-49E7-A34B-D5701E8BC458Q37118132-BFACA552-7B80-44FA-AD7E-28EB0C66F994Q37335477-3D472788-D300-4A7D-A2D4-B7A8791E4A38Q42077699-3A17AB97-D60F-48A6-8EE0-37C4F0C136BA
P2860
Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cognate stimulatory B-cell-T-c ...... ed by glycoconjugate vaccines.
@ast
Cognate stimulatory B-cell-T-c ...... ed by glycoconjugate vaccines.
@en
Cognate stimulatory B-cell-T-c ...... ed by glycoconjugate vaccines.
@nl
type
label
Cognate stimulatory B-cell-T-c ...... ed by glycoconjugate vaccines.
@ast
Cognate stimulatory B-cell-T-c ...... ed by glycoconjugate vaccines.
@en
Cognate stimulatory B-cell-T-c ...... ed by glycoconjugate vaccines.
@nl
prefLabel
Cognate stimulatory B-cell-T-c ...... ed by glycoconjugate vaccines.
@ast
Cognate stimulatory B-cell-T-c ...... ed by glycoconjugate vaccines.
@en
Cognate stimulatory B-cell-T-c ...... ed by glycoconjugate vaccines.
@nl
P2093
P2860
P1476
Cognate stimulatory B-cell-T-c ...... ed by glycoconjugate vaccines.
@en
P2093
A H Sharpe
A K Brigtsen
A K Chandraker
D L Kasper
H K Guttormsen
M H Sayegh
P2860
P304
P407
P577
1999-12-01T00:00:00Z